Use of sulglicotide for the treatment of mucositis

Details Use of sulglicotide for the treatment of mucositis Use of sulglicotide for the treatment of mucositis

2005-05-12

2010-02-16

Weber, Jon P (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S023000, C424S485000, C424S488000, C424S499000, C530S395000

Reexamination Certificate

active

07662777

ABSTRACT:
A method for the treatment and/or prevention of mucositis due to an antitumour treatment which comprises the administration of a composition containing suiglicotide to a patient in needs of said antitumour treatment.

REFERENCES:
patent: 5085867 (1992-02-01), Farolfi et al.
patent: 5496828 (1996-03-01), Cullinan et al.
patent: 6274601 (2001-08-01), Cullinan
patent: 2003/0064913 (2003-04-01), Sonis
patent: 2003/0236217 (2003-12-01), Shalwitz et al.
patent: 0 274 745 (1988-07-01), None
patent: WO 92/18153 (1992-10-01), None
Piotrowski et al. Enhancement in Gastric Mucosal EGF and PDGF Receptors Expression with Ulcer Healing by Sulglycotide, 1995, Genral Pharmacology, vol. 26, No. 4, pp. 749-753.
Slomiany et al. Suppression of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by sulglycotide, 1999, General Pharmacology, vol. 32, pp. 251-257.
Slomiany et al. Omerazole Failsto Suppress Up-Regulation of Gastric Mucosal Endothelin-Converting Enzyme-1 by Helicobacter Pylori Lipopolysaccharide, 2000, Journal of Physiology and Pharmacology, vol. 51, No. 3, pp. 421-431.
Database Biosis 'Online! Biosciences Information Service, 1995, “Enhancement in gastric mucosal EGF and PDGF receptor expression with ulcer healing by sulglycotide” Abstract.
Demarosi, F. et al, Prevention and Treatment of Chemo- and Radiotherapy-Induced Oral Mucositis, Minerva Stomatologica, 2002, pp. 173-186, vol. 51.
Pico, J., et al, Mucositis: Its Occurrence, Consequences, and Treatment in the Oncology Setting, The Oncologist, 1998, pp. 446-451, vol. 3.
Peterson, Douglas E., Research advances in oral mucositis, Current Opinion in Oncology, 1999, pp. 261-266, vol. 11.
Plevova, P., Prevention and treatment of chemotherapy- and radiotherapy- induced oral mucositis: a review, Oral Oncology, 1999, pp. 453-470, vol. 35.
Porro, G. B., et al, Sulglycotide in the Prevention of Nonsteroidal Anti-inflammatory Drug-Induced Gastroduodenal Mucosal Injury, Sulglycotide in Preventing Mucosal Injury, 1993, pp. 875-878, vol. 28 (10).
Slomiany, B.L., et al, Endothelin-1, Interleukin-4 and Nitric Oxide Synthase Modulators of Gastric Mucosal Injury by Indomethacin: Effect of Antiulcer Agents, Journal of Physiology and Pharmacology, 1992, pp. 197-210, vol. 50 (2).
Sonis, S.T., Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity, Oral Oncology, 1998, pp. 39-43, vol. 34.

Affiliated with

Also associated with

Rating

Use of sulglicotide for the treatment of mucositis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of sulglicotide for the treatment of mucositis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of sulglicotide for the treatment of mucositis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4214116